[1] 国家卫生健康委员会. 全血和成分血使用:WS/T 623—2018[S]. 北京:中国标准出版社,2018. [2] 英国血液学标准委员会(BCSH),输血特别委员会. 血小板输注指南[J]. 国外医学(输血及血液学分册),2003, 26(5):459-466. [3] 阳雪新,袁咏梅,吴兆勇,等. ABO次侧不相合血小板输注的有效性和安全性初步研究[J]. 临床输血与检验,2024, 26(1):42-48. [4] 国家质量监督检验检疫总局,中国国家标准化管理委员会. 全血及成分血质量要求:GB 18469—2012[S]. 北京:中国标准出版社,2012. [5] Gunson H H,Stratton F,Cooper D G,et al.Primary immunization of Rh-negative volunteers[J]. Br Med J, 1970,1(5696):593-595. [6] Jakobowicz R,Williams L,Silberman F.Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood[J]. Vox Sang,1972, 23(4):376-381. [7] 尚红,王毓三,申子瑜,主编. 全国临床检验操作规程[M].4版. 北京:人民卫生出版社,2015:5-7. [8] Cavagnetto C,Alejo Blanco R,McKenna H,et al. Residual red cells in blood components:A multisite study of fully automated enumeration using a hematology analyzer[J]. Transfusion,2021,61(2):568-578. [9] Canellini G,Rubin O,Delobel J,et al.Red blood cell microparticles and blood group antigens:an analysis by flow cytometry[J]. Trasfusione Del Sangue,2012, 10(Suppl 2):s39-s45. [10] 徐文皓,李志强. 血浆置换术治疗高效价抗-D患者效果评价[J]. 中国输血杂志,2011,24(9):752-754. [11] Thibault L,de Grandmont M J,Cayer M P,et al. Rhesus D antigenic determinants on residual red blood cells in apheresis and buffy coat platelet concentrates[J]. Transfus Med Hemother,2020,47(2):129-134. [12] Gammon R R,Almozain N,Hermelin D,et al.RhD-alloimmunization in adult and pediatric trauma patients[J]. Transfus Med Rev,2024,38(4):150842. [13] Cid J,Yazer M H,Lozano M.Platelet transfusion and respecting patient D type[J]. Curr Opin Hematol,2015, 22(6):540-546. [14] Baldwin M L,Ness P M,Scott D,et al.Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients[J]. Transfusion,1988,28(4):330-333. [15] Cid J,Carbassé G,Pereira A,et al.Platelet transfusions from D+ donors to D- patients:a 10-year follow-up study of 1014 patients[J]. Transfusion,2011,51(6):1163-1169. [16] 刘敏,彭涛,于晶晶,等. 肿瘤患者血小板输注致迟发性血清学输血反应的临床特征及输血策略[J]. 中国输血杂志, 2024,37(5):491-494. [17] Moran C, Zepeda A, Diaz H.Antígeno plaquetario humano:breve revisión del tema y su significado clínico[Human platelet antigen:brief review of the topic and its clinical significance][J]. Rev Med Inst Mex Seguro Soc. 2024,62(suppl 1):1-6. [18] 郭敏,李建民,刘建辉,等. 去白细胞混合浓缩血小板制备的质量控制及临床应用效果观察[J]. 中国输血杂志, 2023,36(11):1025-1028. [19] 胡志颖. 单采血小板对血小板质量及输注疗效的临床分析[J]. 现代诊断与治疗,2018,29(24):4018-4020. [20] Estcourt L J,Birchall J,Allard S,et al.Guidelines for the use of platelet transfusions[J]. Br J Haematol,2017, 176(3):365-394. [21] 朱雯雯,李莺,宋志群,等. Rh阴性患者输注Rh阳性单采血小板的疗效分析[J]. 临床血液学杂志,2016,29(12):951-953. [22] 杜霞,李茜,涂源泉,等. 昆明地区RhD初筛阴性献血者RHD基因多态性及分子机制研究[J]. 临床输血与检验, 2026,28(1):97-102. [23] 张瑛,陈锦荣,林甲进. 22例Del型外显子基因测序分析[J]. 临床血液学杂志,2025,38(10):757-760. [24] Kitazawa J,Nollet K,Morioka H,et al.Non-D Rh antibodies appearing after apheresis platelet transfusion:stimulation by red cells or microparticles?[J]. Vox Sang, 2011,100(4):395-400. [25] Coughlan C,Bruce K D,Burgy O,et al.Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses[J]. CP Cell Biology,2020,88:e110. [26] Lai J J,Chau Z L,Chen S Y,et al.Exosome processing and characterization approaches for research and technology development[J]. Adv Sci (Weinh),2022, 9(15):e2103222. [27] 向东,范亮峰,刘曦,等. 免疫性溶血性输血反应100例分析[J]. 临床输血与检验,2022,24(1):11-15. [28] Heim M U,Böck M,Kolb H J,et al.Intravenous anti-D gammaglobulin for the prevention of Rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases[J]. Vox Sang,1992, 62(3):165-168. |